KR20010092539A - A beverage for mitigating hangover and manufacturing method there of - Google Patents
A beverage for mitigating hangover and manufacturing method there of Download PDFInfo
- Publication number
- KR20010092539A KR20010092539A KR1020000014546A KR20000014546A KR20010092539A KR 20010092539 A KR20010092539 A KR 20010092539A KR 1020000014546 A KR1020000014546 A KR 1020000014546A KR 20000014546 A KR20000014546 A KR 20000014546A KR 20010092539 A KR20010092539 A KR 20010092539A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- hangover
- weight
- water
- drink
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 235000013361 beverage Nutrition 0.000 title abstract description 9
- 230000000116 mitigating effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000012907 honey Nutrition 0.000 claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 10
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 10
- 235000008397 ginger Nutrition 0.000 claims abstract description 10
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 6
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 16
- 240000006891 Artemisia vulgaris Species 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 229930091371 Fructose Natural products 0.000 claims description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 7
- 235000002789 Panax ginseng Nutrition 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- 229940010454 licorice Drugs 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 235000015468 Lycium chinense Nutrition 0.000 claims description 5
- 229930003270 Vitamin B Natural products 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 235000017803 cinnamon Nutrition 0.000 claims description 5
- 235000015203 fruit juice Nutrition 0.000 claims description 5
- 235000019156 vitamin B Nutrition 0.000 claims description 5
- 239000011720 vitamin B Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 241000222336 Ganoderma Species 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 235000014214 soft drink Nutrition 0.000 claims description 3
- 235000021018 plums Nutrition 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 2
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 claims 1
- 229940119569 wormwood extract Drugs 0.000 claims 1
- 239000000654 additive Substances 0.000 abstract description 3
- 239000002075 main ingredient Substances 0.000 abstract description 2
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 3
- 241000092668 Artemisia capillaris Species 0.000 abstract 3
- 244000018795 Prunus mume Species 0.000 abstract 3
- 235000011158 Prunus mume Nutrition 0.000 abstract 3
- 244000080208 Canella winterana Species 0.000 abstract 1
- 235000008499 Canella winterana Nutrition 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 229940017545 cinnamon bark Drugs 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 10
- 230000003908 liver function Effects 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 4
- 241000202807 Glycyrrhiza Species 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 210000000941 bile Anatomy 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 102000002852 Vasopressins Human genes 0.000 description 2
- 108010004977 Vasopressins Proteins 0.000 description 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004149 ethanol metabolism Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000020458 relaxation drink Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 229960003726 vasopressin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 241000256837 Apidae Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/606—Fructose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 숙취완화 음료 및 제조방법에 관한 것으로서, 보다 상세하게는 인진쑥, 매실 및 꿀을 주성분으로 하여 일반적인 숙취증상의 완화 뿐만 아니라 간기능을 보호할 수 있는 숙취완화 음료 및 그 제조방법에 관한 것이다.The present invention relates to a hangover relieving drink and a manufacturing method, and more particularly, to a hangover relieving drink that can protect not only general hangover symptoms but also liver function with main ingredients of jinjin mugwort, plum and honey. .
과단한 음주는 일시적으로는 두근거림, 두통, 갈증, 멀미, 위장장애, 설사 등의 숙취증상을 유발하며, 만성적으로는 지방간, 간경화 등의 질환을 일으킬 수 있다. 상기 숙취증상 중 두통은 두뇌 혈관의 확장작용 때문이며, 갈증과 탈수현상은 에탄올이 뇌하수체에서 분비되는 항이뇨호르몬인 바소프레신의 분비를 억제하므로써 생기는 에탄올의 이뇨작용 때문이고, 소화기관 이상은 위산분비의 증가때문인 등 숙취의 원인은 다양할 수 있지만 일반적으로는 숙취는 에탄올 분해산물인 아세트알데하이드가 축적되어 일어나는 것으로 알려져있다.Excessive drinking temporarily causes hangover symptoms such as palpitations, headaches, thirst, motion sickness, gastrointestinal disorders and diarrhea, and chronic liver and liver cirrhosis. The headache of the hangover is due to the expansion of the brain vessels, thirst and dehydration is due to the diuretic action of ethanol produced by inhibiting the secretion of vasopressin, an antidiuretic hormone secreted from the pituitary gland, the gastrointestinal abnormality increases gastric acid secretion The causes of hangovers may vary, but in general, hangovers are known to occur due to the accumulation of acetaldehyde, a ethanol decomposition product.
이러한 아세트알데하이드의 축적 과정을 살펴보면 다음과 같다.The accumulation process of acetaldehyde is as follows.
에탄올 대사과정은 에탄올이 알코올 디하이드로게나제(alcohol dehydrogenase)에 의하여 아세트알데하이드로 전환되는 첫단계와 아세트알데하이드가 알데하이드 디하이드로게나제에 의해 아세테이트로 전환되는 둘째 단계로 크게 구분할 수 있다. 정상적인 생리 상태하에서는 알데하이드 디하이드로게나제의 활성이 알코올 디하이드로게나제의 활성보다 높기 때문에 에탄올이 아세트알데하이드를 거쳐 즉시 아세테이트로 전환되어 구연산회로로 유입되어 아세트알데하이도의 축적이 일어나지 않는다. 그러나, 에탄올 섭취량이 많아지면 에탄올이 아세트알데하이드를 거쳐 아세테이트로 전환되는 과정에서 NAD가 NADH로 환원됨에 따라 세포내의 NADH/NAD의 비율이 증가하게 된다. 이렇게 NADH/NAD의 비율이 증가하게 되면 구연산 회로의 활성이 저해되어 아세트알데하이드가 아세테이트로 전환되지 못하여 독성을 가지는 아세트알데하이드가 세포내에 축적되는 것이다.Ethanol metabolism can be divided into two stages: ethanol is converted to acetaldehyde by alcohol dehydrogenase and acetaldehyde is converted to acetate by aldehyde dehydrogenase. Under normal physiological conditions, the activity of aldehyde dehydrogenase is higher than that of alcohol dehydrogenase, so ethanol is immediately converted to acetate via acetaldehyde and introduced into the citric acid cycle so that no accumulation of acetaldehyde is caused. However, as the ethanol intake increases, the ratio of NADH / NAD in the cells increases as NAD is reduced to NADH during the conversion of ethanol to acetaldehyde through acetate. When the ratio of NADH / NAD is increased, the activity of the citric acid cycle is inhibited and acetaldehyde is not converted into acetate, and toxic acetaldehyde accumulates in the cell.
또한, 에탄올 대사과정에서 생성된 NADH는 지방산의 산화를 억제하고 중성지방의 합성을 촉진하여 지방간과 고지혈증 등을 유발하게 된다.In addition, NADH produced during ethanol metabolism inhibits the oxidation of fatty acids and promotes the synthesis of triglycerides, leading to fatty liver and hyperlipidemia.
지금까지 개발되어 있는 숙취완화제는 비타민, 아미노산, 당분 등을 혼합한 제재로서 아세트알데하이드 축적에 의한 숙취를 완화하는데 효과가 있을 뿐 간기능을 저해하는 중성지방의 축적을 방지하기에는 역부족인 면이 있다. 따라서 숙취해소 뿐만 아니라 간기능을 보전할 수 있는 새로운 숙취완화제가 요구되고 있다.Hangover emollients developed until now is a mixture of vitamins, amino acids, sugars, etc. is effective in relieving hangover due to acetaldehyde accumulation, but there is an insufficiency in preventing the accumulation of triglycerides that inhibit liver function. Therefore, there is a need for a new hangover relieving agent that can preserve liver function as well as relieve hangovers.
상기한, 종래의 숙취완화제들의 문제점을 보완하는데 있어서, 간기능 향상에 탁월한 효과가 있는 것으로 알려져 있는 인진쑥을 비롯한 다른 여러 가지 약제를 이용하여 보다 나은 숙취완화제를 제공하는 것에 본 발명에 목적이 있다.In order to solve the problems of the conventional hangover relaxants, it is an object of the present invention to provide a better hangover relaxer by using a variety of other drugs, such as jinjin mugwort known to have an excellent effect on improving liver function.
또한, 인진쑥의 경우는 고유의 쓴 맛으로 인하여 상용화된 음료를 제조하는데 어려움이 있고 이러한 쓴 맛의 변화를 추구하기 위해 다른 첨가제와 혼합 시 약효의 변질을 우려가 있는데 본 발명은 간기능 향상 효능의 변화없이 쓴 맛을 완화하면서 첨가제와 상충하지 않고 효능을 보완시키는 방법을 제공하는 것 역시 본 발명의 목적이라 할 수 있다.In addition, in case of Injin mugwort, it is difficult to prepare a commercialized drink due to the inherent bitter taste, and there is a concern that the drug efficacy may be altered when mixed with other additives in order to change the bitter taste. It is also an object of the present invention to provide a method that complements the efficacy without compromising additives while relieving bitter taste without change.
상기 기술적 과제를 달성하기 위하여, 본 발명은 인진쑥 추출물 0.1 내지 30중량%, 매실 추출물 0.1 내지 20중량% 및 꿀 0.1 내지 20중량%를 포함하며, 나머지 함량은 물인 것을 특징으로 하는 숙취완화용 음료를 제공한다.In order to achieve the above technical problem, the present invention comprises 0.1 to 30% by weight of the extract of jinjinjin, 0.1 to 20% by weight of plum extract and 0.1 to 20% by weight of honey, the remaining content is a drink for a hangover characterized in that the water to provide.
본 발명에 따른 숙취완화 음료는 갈근, 홍삼, 감초, 생강, 대추, 계피, 구기자 및 영지로 이루어진 군에서 선택되는 하나 이상의 추출물 및/또는 과일즙, 과당, 비타민C 및 비타민B로 이루어진 군에서 선택되는 어느 하나 이상을 0.1 내지 5중량% 더 포함하는 것이 바람직하다.Hangover relieving drink according to the present invention is selected from the group consisting of one or more extracts selected from the group consisting of brown root, red ginseng, licorice, ginger, jujube, cinnamon, wolfberry and ganoderma and / or fruit juice, fructose, vitamin C and vitamin B It is preferable to further include 0.1 to 5% by weight of any one or more.
상기 다른 기술적 과제를 달성하기 위하여, 본 발명은In order to achieve the above another technical problem, the present invention
(a) 건조한 인진쑥을 20 내지 30℃ 물로 추출하여 인진쑥 추출물을 제조하는 단계;(a) extracting the dried phosphorus mugwort with 20 to 30 ° C. water to prepare a phosphorus mugwort extract;
(b) 매실을 95 내지 100℃의 물로 추출한 후 상온으로 냉각하여 매실추출물을 제조하는 단계; 및(b) extracting plums with water at 95 to 100 ° C. and cooling them to room temperature to prepare plum extracts; And
(c) 상기 인진쑥 추출물, 상기 매실 추출물 및 꿀을 물에 부가하고 균일하게 혼합한 후 여과하는 단계를 포함하는 것을 특징으로 하는 숙취완화 음료의 제조방법을 제공한다.(c) the method of producing a hangover relief drink comprising the step of adding the phosphorus extract, the plum extract and honey to the water and then uniformly mixed.
본 발명에 따른 제조방법은Manufacturing method according to the invention
(d) 갈근, 홍삼, 감초, 생강, 대추, 계피, 구기자 및 영지로 이루어진 군에서 선택되는 하나 이상을 95 내지 100℃의 물로 추출한 후 냉각하여 추출물을 제조하는 단계; 및(d) extracting at least one selected from the group consisting of brown root, red ginseng, licorice, ginger, jujube, cinnamon, wolfberry and ganoderma with water at 95 to 100 ° C., followed by cooling to prepare an extract; And
(e) 상기 (c) 단계의 결과물에 (d) 단계의 추출물을 부가하여 균일하게 혼합한 후 여과하는 단계를 더 포함하는 것이 바람직하다.(e) It is preferable to further include the step of adding the extract of step (d) to the resultant of step (c) to uniformly mix and then filter.
또한, 본 발명에 따른 제조방법은In addition, the manufacturing method according to the present invention
(f) 상기 (c) 단계의 결과물 또는 (e) 단계의 결과물에 과일즙, 과당, 비타민C 및 비타민B로 이루어진 군에서 선택되는 어느 하나 이상을 부가하여 균일하게 혼합한 후 여과하는 단계를 더 포함하는 것이 바람직하다.(f) adding at least one selected from the group consisting of fruit juice, fructose, vitamin C and vitamin B to the result of step (c) or the result of step (e), followed by uniformly mixing and filtering It is preferable to include.
이하, 본 발명에 따른 숙취완화 음료 및 이의 제조방법에 대하여 설명하기로 한다.Hereinafter, a hangover-relieving drink and a manufacturing method thereof according to the present invention will be described.
본 발명에 따른 숙취완화음료를 제조하기 위해서는 인진쑥 추출물과 매실 추출물의 제조가 우선되어야 하는데 그 과정을 살펴보면 다음과 같다.In order to prepare a hangover relaxation beverage according to the present invention, the preparation of Injin mugwort extract and plum extract should be prioritized.
인진쑥 추출물은 인진쑥의 뿌리를 제외한 지상부를 건조한 후에 20 내지 30℃의 온수를 이용하여 추출한 후 여과하여 제조된다. 이러한 추출물을 저온에서 농축하여 고형분 함량이 90% 이상인 인진쑥 엑기스를 사용할 수도 있다.Phosphorus mugwort extract is prepared by extracting the ground portion except for the root of phosphorus mugwort and extracting using hot water at 20 to 30 ° C., followed by filtration. Such extracts may be concentrated at low temperatures to use jinjin extract having a solid content of 90% or more.
다음으로 매실 추출물은 인진쑥 추출시와는 달리 90 내지 100℃의 열수를 이용하여 추출한 후 여과하여 제조된다. 이러한 추출물을 고온에서 농축하여 고형분 함량이 90% 이상인 매실 엑기스를 사용할 수도 있다.Next, the plum extract is prepared by extracting with hot water of 90 to 100 ℃ unlike jinjin extract extracted after filtration. Such extracts may be concentrated at high temperature to use plum extract having a solid content of at least 90%.
상기와 같이 제조한 인진쑥 추출물 0.1 내지 30중량%와 매실 추출물 0.1 내지 20중량%에 0.1 내지 20중량%의 꿀과 물을 부가하여 100중량%가 되도록한 후 이를 균일하게 혼합한 후를 이 혼합물을 여과하여 이물질을 제거하면 본 발명에 따른 숙취완화 음료가 1차적으로 완성되는 것이다.0.1 to 30% by weight of the jinjin jinja extract prepared as described above and 0.1 to 20% by weight of honey extract and 0.1 to 20% by weight of honey and water was added to 100% by weight and then mixed evenly to this mixture Removing foreign matter by filtration is to complete the hangover relaxation beverage according to the present invention first.
상술한 바와 같은 본 발명에 따른 제조방법에서 사용되는 물은 정제수인 것이 바람직하다. 그리고, 인진쑥 추출물의 제조시에 20 내지 30℃의 온수를 사용하는 이유는 열수에 의한 추출의 경우에 인진쑥의 효능이 변질될 우려가 있기 때문이다.Water used in the production method according to the present invention as described above is preferably purified water. In addition, the reason for using hot water at 20 to 30 ° C. in the preparation of the extract of Injin mugwort is that the efficacy of Injin mugwort may be altered in the case of extraction by hot water.
1차적으로 완성한 본 발명에 따른 숙취완화 음료는 캔, 병 등에 포장하고 멸균하여 제품으로 판매할 수 있으나 다음과 성분들을 더 부가하여 제조될 수도 있다.The hangover softening beverage according to the present invention, which is primarily completed, may be sold as a product by packaging and sterilizing cans, bottles, etc., but may be prepared by further adding the following ingredients.
갈근, 홍삼, 감초, 생강, 대추, 계피, 구기자 및 영지로 이루어진 군에서 선택되는 하나 이상을 95 내지 100℃의 물로 추출하고 여과한 후 냉각하여 추출물을 0.1 내지 5중량% 및/또는 과일즙, 과당, 비타민C 및 비타민B로 이루어진 군에서 선택되는 어느 하나 이상을 0.1 내지 5중량% 더 부가한 후 균일하게 혼합하여 본 발명에 따른 숙취완화용 음료를 제조할 수도 있다.At least one selected from the group consisting of brown root, red ginseng, licorice, ginger, jujube, cinnamon, wolfberry and ganoderma extract with water of 95 to 100 ℃, filtered and cooled to extract the extract from 0.1 to 5% by weight and / or fruit juice, Fructose, vitamin C and vitamin B may be prepared by further adding 0.1 to 5% by weight of any one or more selected from the group consisting of and then uniformly mixed drink for the hangover.
이하, 본 발명에서 사용한 생약들의 효능에 대하여 간단히 살펴보면 다음과 같다.Hereinafter, briefly look at the efficacy of the herbal medicines used in the present invention.
1) 인진쑥은 이담작용이 높아 담즙을 많이 나오게 하는 동시에 담즙속의 콜리친, 빌리루빈을 밖으로 배출하고 간효소의 활성화와 지방분해작용, 간조직의재생능력을 향상시켜 지방간이나 황달 등에 효과가 있어서 간기능의 보전하는데 도움이 된다.1) Injin mugwort has a high bile effect, which makes bile out and at the same time releases colchicine and bilirubin in the bile and improves liver enzyme activation, lipolysis, and regeneration of liver tissue. It helps to preserve.
2) 매실은 구연산을 포함하고 있어서 당질의 대사를 촉진하여 피로회복을 도우며, 또한 유기산을 다량 함유하고 있어서 위장의 운동을 활발하게 하고 식욕을 돋우며 특히 매실이 함유하는 피크린산은 간장의 기능을 활성화하기 때문에 숙취완화에 도움이 된다.2) Plum contains citric acid, which promotes the metabolism of sugars to help fatigue, and also contains large amounts of organic acid, which promotes gastrointestinal motility and stimulates appetite. It helps to relieve hangovers.
3) 꿀은 꿀벌의 벌집에서 얻은 당류 물질로서 비위와 폐, 기를 보하여 위 십이지장 궤양, 만성 기관지염, 고혈압, 숙취 등에 사용된다.3) Honey is a saccharide substance obtained from honeycomb of honey bees and is used for gastric duodenal ulcer, chronic bronchitis, high blood pressure, hangover and so on.
4) 갈근은 해독작용과 히스타민-2에 의한 위산분비를 억제하므로서 에탄올 섭취에 의한 위장 질환을 억제할 수 있으며, 간내 지방축적을 방지하고 섬유화를 억제한다.4) Root can inhibit the detoxification and gastric acid secretion by histamine-2, thereby inhibiting gastrointestinal diseases caused by ethanol intake, preventing liver fat accumulation and inhibiting fibrosis.
5) 생강은 간장의 기능을 활발하게 하고 수분대사를 원활하게 하는 작용이 있어 일반적 숙취에 탁월한 효과가 있으며, 또한 생강에 포함하는 징게롤(gingerol)은 위액분비와 연동운동을 촉진하고 소화를 돕는다.5) Ginger has the effect of activating the function of the liver and smoothing the metabolism of water, which is excellent for general hangover. In addition, ginger included in ginger promotes gastric juice and peristalsis and helps digestion. .
6) 구기자의 경우는 다량의 비타민을 함유하고 있어서 숙취해소에 효과가 있을뿐만 아니라 간세포내 지방축적과 간세포 파괴를 억제하는 기능을 가지고 있다.6) Goji berries contain a large amount of vitamins, which are effective in relieving hangovers and have the function of inhibiting fat accumulation and hepatocellular destruction in hepatocytes.
7) 당귀는 간을 보호하고 글리코겐의 감소를 방지하는 효과가 뛰어나다.7) Angelica is excellent for protecting liver and preventing glycogen reduction.
8) 홍삼은 운동피로 및 음주 후의 간내의 글리코겐 감소를 억제하여 정상수준으로 회복시키는 효과가 있다.8) Red ginseng has the effect of restoring the level of glycogen in the liver after exercise fatigue and drinking to restore to normal level.
9) 감초는 상술한 모든 성분들을 조화시키는 역할을 한다.9) Licorice serves to harmonize all the above-mentioned ingredients.
상술한 바와 같이 본 발명에 사용되는 개발적으로도 숙취 및 간기능 보호에 효과가 있지만 본 발명자의 연구에 따른 적절한 성분비로 조합하여 사용할 경우에 더욱 뛰어난 효과를 발휘하는 것을 알게되어 본 발명을 완성한 것이다.The development of the present invention as described above is also effective in protecting the hangover and liver function, but when used in combination with the appropriate component ratio according to the inventors of the present invention was found to exhibit more excellent effect to complete the present invention. .
이하, 본 발명을 하기 실시예를 들어 설명하기로 하되, 본 발명이 하기 실시예로만 한정되는 것은 아니다.Hereinafter, the present invention will be described with reference to the following examples, but the present invention is not limited only to the following examples.
<실시예 1><Example 1>
인진쑥을 25℃의 정제수로 추출한 추출물 20중량%, 매실을 약 100℃의 열정제수로 추출하여 상온으로 냉각한 추출물 20중량%, 꿀 4중량% 및 갈근, 감초, 당귀, 생강, 홍삼을 동일한 양으로 혼합한 혼합물을 약 100℃의 열정제수로 추출하여 상온으로 냉각한 추출물 4중량%에 100중량%가 되도록 정제수를 가하고 상온에서 30분간 배합하여 500μ포어(pore) 추출가능한 활성탄으로 여과한 후 본 발명에 따른 숙취완화음료를 제조하였다.20% by weight of extract extracted from Injin mugwort with purified water at 25 ° C., 20% by weight of extract extracted with plum water at about 100 ° C. Passion water, 4% by weight of honey and the same amount of root, licorice, Angelica, ginger, red ginseng The mixture was extracted with passion water at about 100 ° C. and purified water was added to 4% by weight of the extract cooled to room temperature to 100% by weight, and then mixed at room temperature for 30 minutes, filtered through 500 μ pore extractable activated carbon. A hangover soft drink according to the invention was prepared.
<실시예 2><Example 2>
과당을 2중량% 더 가한 것을 제외하고는 실시예 1과 동일한 방법으로 본 발명에 따른 본 발명에 따른 숙취완화 음료를 제조하였다.A hangover relieving drink according to the present invention was prepared in the same manner as in Example 1 except for adding 2% by weight of fructose.
<실시예 3><Example 3>
인진쑥 추출물의 함량을 25중량%로 늘리고 과당을 2중량% 더 가한 것을 제외하고는 실시예 1과 동일한 방법으로 본 발명에 따른 숙취완화 음료를 제조하였다.Hangover relieving drink according to the present invention was prepared in the same manner as in Example 1 except that the content of the extract of Injin mugwort was increased to 25% by weight and 2% by weight of fructose was added.
<실시예 4><Example 4>
인진쑥 추출물의 함량을 30중량%로 늘리고 과당을 2중량% 더 가한 것을 제외하고는 실시예 1과 동일한 방법으로 본 발명에 따른 숙취완화 음료를 제조하였다.Hangover relieving drink according to the present invention was prepared in the same manner as in Example 1 except that the content of the extract of Injin mugwort was increased to 30% by weight and 2% by weight of fructose was added.
<효능 시험><Efficacy test>
상술한 바와 같이 제조한 본 발명에 따른 숙취완화음료의 효능을 알아보기 위하여 다음과 같은 임상 실험을 하였다.In order to determine the efficacy of the hangover relaxation beverage according to the present invention prepared as described above was carried out the following clinical experiment.
대조군과 시험군으로 각각 병력이 없는 30대의 성인 남자 12명을 무작위으로 선발하였다. 시험전 시험군과 대조군의 연령에 따른 표준편차는 임상적으로 유의하지 않았으며(표준오차<0.05), 시험전 혈액에서 체취한 간기능 검사상 SGOT, SGPT, γ-GTP도 모두 임상적인 차이는 없었다(표준오차<0.05).Twelve adult men in their thirties with no history were randomly selected as the control and test groups. The standard deviation of the test group and the control group was not clinically significant (standard error <0.05), and there were no significant differences in the SGOT, SGPT, and γ-GTP levels in the liver function tests. There was no (standard error <0.05).
시험군과 대조군 모두 4일간 1일 약 에탄올 30mg(소주 1/3병)을 음복한 후 5일째부터 시험군은 상술한 바와 같이 제조한 본 발명에 따른 숙취완화 음료 200ml씩 4일간 복용한 후 9일째부터 3일간 혈액을 채취하여 SGOT, SGPT, γ-GTP를 측정하여 그 결과를 표 1에 나타냈다.In the test group and the control group, after taking about 30 mg of ethanol (1/3 bottles of soju) per day for 4 days from day 5, the test group took 200 ml of hangover-relieving beverages according to the present invention prepared for 4 days, and then 9 days. Blood was collected for 3 days from day 1 and SGOT, SGPT and γ-GTP were measured and the results are shown in Table 1.
상기 표 1을 보면 대조군의 경우에는 SGOT, SGPT, γ-GTP 모두가 임상적으로 의미있게 상승하였으나(표준오차<0.05), 실험군의 경우에는 임상적으로 의미있게 상승하지 않았다(표준오차<0.05). 오히려 실시예 3의 경우에는 약간 감소한 것으로 나타났다.In Table 1, SGOT, SGPT, and γ-GTP were all elevated clinically in the control group (standard error <0.05), but did not increase in the experimental group (standard error <0.05). . Rather, in the case of Example 3 it appeared to decrease slightly.
이와 같은 실험으로 볼 때 장기적인 간기능 상승의 효과와 간기능 보전 효과를 기대할 수 있는 숙취완화의 효능을 입증할 수 있었다.These experiments proved the effects of hangover relief that could be expected to have long-term effects on liver function and liver function.
이상에서 살펴본 바와 같이 본 발명에 따른 숙취완화 음료는 일반적인 숙취완화음료와는 차별화되어 숙취증상의 탁월한 완화효과 뿐만 아니라 간기능의 상승 및 보전 효과도 동시에 가지고 있는 우수한 음료임을 알 수 있다.As described above, the hangover relaxation drink according to the present invention is distinguished from the general hangover relaxation drink, it can be seen that it is an excellent drink having not only an excellent alleviation effect of the hangover symptoms but also an increase and preservation effect of liver function.
또한, 본 발명에 따른 방법으로 숙취완화음료를 제조하는 경우에는 인진쑥을 상온 정도의 물로 추출하여 제조함으로써 인진쑥 본래의 효능을 변질시키지 않고 제조가 가능한 장점도 가지고 있다.In addition, when manufacturing a hangover soft drink by the method according to the present invention has the advantage that can be produced without altering the original efficacy of the ginjinmyeong by extracting the ginjinmyeong with water of about room temperature.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000014546A KR20010092539A (en) | 2000-03-22 | 2000-03-22 | A beverage for mitigating hangover and manufacturing method there of |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000014546A KR20010092539A (en) | 2000-03-22 | 2000-03-22 | A beverage for mitigating hangover and manufacturing method there of |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20010092539A true KR20010092539A (en) | 2001-10-26 |
Family
ID=19657508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000014546A KR20010092539A (en) | 2000-03-22 | 2000-03-22 | A beverage for mitigating hangover and manufacturing method there of |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20010092539A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030079289A (en) * | 2002-04-03 | 2003-10-10 | 최동식 | The carbonated soft drinks a manufacturing process and a composition of ling indigestion hangover cures. |
KR100420767B1 (en) * | 2002-01-31 | 2004-03-02 | 현 용 이 | The preparing method of the ingin-mugwort extract in which the components of bitter taste were selectively removed, and the functional liquid food of using it |
KR100429141B1 (en) * | 2001-05-17 | 2004-04-28 | 남궁순자 | health food beverage use mugwort and it's manufacture method |
KR20040046015A (en) * | 2002-11-26 | 2004-06-05 | 염동순 | Drink for Reducing Snore and Hanover and Method for Manufacturing Thereof |
KR100504351B1 (en) * | 2002-10-18 | 2005-07-27 | (주)바이오뉴트리젠 | Food composition for reducing alcoholic hangup containing plant extracts or powders |
KR100649128B1 (en) * | 2005-08-10 | 2006-11-27 | 이수복 | Manufacturing method of functional food composition including maesil |
KR100829048B1 (en) * | 2006-09-22 | 2008-05-19 | 충북대학교 산학협력단 | Development of Mugwort Extract with High Anti-oxidant Activities |
KR101368747B1 (en) * | 2011-12-06 | 2014-03-13 | (주)태영에프앤아이 | Beverage composition for treating hangover |
CN104305437A (en) * | 2014-09-29 | 2015-01-28 | 洛阳人康食品有限公司 | Herba artemisiae scopariae plant beverage and preparation method thereof |
CN104687199A (en) * | 2015-03-30 | 2015-06-10 | 黄振忠 | Preparation method of kudzu root beverage |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920011393A (en) * | 1990-12-07 | 1992-07-24 | 김종채 | How to make plum juice |
CN1081078A (en) * | 1992-07-11 | 1994-01-26 | 浙江省科学院柑桔研究所 | The autofrettage of preserved plum juice beverage and preserved plum flavor beverage |
JPH06277014A (en) * | 1993-03-31 | 1994-10-04 | Koichi Masago | Healthy beverage and its production |
KR960016779A (en) * | 1994-11-14 | 1996-06-17 | 강성훈 | Health mixed drink composition |
KR980000186A (en) * | 1997-10-07 | 1998-03-30 | 용태웅 | Manufacturing method of mugwort drink |
-
2000
- 2000-03-22 KR KR1020000014546A patent/KR20010092539A/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR920011393A (en) * | 1990-12-07 | 1992-07-24 | 김종채 | How to make plum juice |
CN1081078A (en) * | 1992-07-11 | 1994-01-26 | 浙江省科学院柑桔研究所 | The autofrettage of preserved plum juice beverage and preserved plum flavor beverage |
JPH06277014A (en) * | 1993-03-31 | 1994-10-04 | Koichi Masago | Healthy beverage and its production |
KR960016779A (en) * | 1994-11-14 | 1996-06-17 | 강성훈 | Health mixed drink composition |
KR980000186A (en) * | 1997-10-07 | 1998-03-30 | 용태웅 | Manufacturing method of mugwort drink |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100429141B1 (en) * | 2001-05-17 | 2004-04-28 | 남궁순자 | health food beverage use mugwort and it's manufacture method |
KR100420767B1 (en) * | 2002-01-31 | 2004-03-02 | 현 용 이 | The preparing method of the ingin-mugwort extract in which the components of bitter taste were selectively removed, and the functional liquid food of using it |
KR20030079289A (en) * | 2002-04-03 | 2003-10-10 | 최동식 | The carbonated soft drinks a manufacturing process and a composition of ling indigestion hangover cures. |
KR100504351B1 (en) * | 2002-10-18 | 2005-07-27 | (주)바이오뉴트리젠 | Food composition for reducing alcoholic hangup containing plant extracts or powders |
KR20040046015A (en) * | 2002-11-26 | 2004-06-05 | 염동순 | Drink for Reducing Snore and Hanover and Method for Manufacturing Thereof |
KR100649128B1 (en) * | 2005-08-10 | 2006-11-27 | 이수복 | Manufacturing method of functional food composition including maesil |
KR100829048B1 (en) * | 2006-09-22 | 2008-05-19 | 충북대학교 산학협력단 | Development of Mugwort Extract with High Anti-oxidant Activities |
KR101368747B1 (en) * | 2011-12-06 | 2014-03-13 | (주)태영에프앤아이 | Beverage composition for treating hangover |
CN104305437A (en) * | 2014-09-29 | 2015-01-28 | 洛阳人康食品有限公司 | Herba artemisiae scopariae plant beverage and preparation method thereof |
CN104687199A (en) * | 2015-03-30 | 2015-06-10 | 黄振忠 | Preparation method of kudzu root beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7270838B2 (en) | Composition for treating chronic venous insufficiencies using an extract of red vine leaves | |
KR100853078B1 (en) | A method for preparation of a hurb composition for removing hangover | |
CN102068682A (en) | Chinese medicinal composition for treating digestive system diseases and preparation method thereof | |
KR20010092539A (en) | A beverage for mitigating hangover and manufacturing method there of | |
CN101543248A (en) | A cold tea especially suitable for 'three high and one acid' population and method for its prepairing | |
KR20120115443A (en) | A medicinal infusion drink removing the effect of hangover and method for manufacturing the same | |
US5482712A (en) | Galenic composition | |
CN110840966A (en) | Composition for relieving alcoholism and chewable tablet containing same | |
KR100392876B1 (en) | A drink for eliminating a hangover and a method for producing the same | |
CN110973625A (en) | Liver-protecting and sobering-up composition based on fructus cannabis and preparation method and application thereof | |
KR100500373B1 (en) | Composition for hangover cures | |
CN111135235A (en) | A composition for preventing and relieving acute alcoholism or alcoholic intoxication | |
KR20020078467A (en) | Drink for tonic liver and Manufacture process the same. | |
KR101365794B1 (en) | The improved composition for relieving hangovers and protecting a liver | |
KR20020041515A (en) | Chinese Medicine Composition for Dissolving Suffer from Aftereffects of Drink and Method of Preparing the Same | |
CN111643563B (en) | Composition for harmonizing stomach, protecting liver and dispelling effects of alcohol and preparation method thereof | |
CN114767826A (en) | Sobering-up and liver-protecting composition, beverage with sobering-up and liver-protecting effects and preparation method of beverage | |
CN104770489A (en) | Composition having anti-oxidation function and preparation method thereof | |
CN113403167A (en) | Agilawood wine for tonifying yang and invigorating kidney | |
KR20020046418A (en) | Tonic compositions and tonic agents comprising the same | |
KR20000026785A (en) | Herb medicine-containing accelerant for alcohol metabolism | |
US20040137084A1 (en) | Treatment of allergic rhinitis | |
CN102872289B (en) | Traditional Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
KR20030037355A (en) | Preparing method of health care composition helpful for asthma's prevention and treatment and composition therof | |
CN109717437A (en) | One kind is relieved the effect of alcohol compound honey paste and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |